Here are four key points:
1. An increasing incidence of ankylosing spondylitis cases as well as a rising awareness of treatments will spur market growth.
2. Market barriers include treatment costliness and lack of skilled surgeons and physiotherapists.
3. North America captures the greatest market share due to the prevalence of ankylosing spondylitis as well as technological advancements.
4. China and India will experience the most rapid growth because of a rising number of AS patients and increasing favorable government initiatives.
More articles on devices:
Medtronic, SeaSpine, Zimmer Biomet & more: 17 key notes
Analysts update price targets of NuVasive stock — 3 quick points
DePuy Synthes, Acumed, Stryker market leaders in Japan device market: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
